Published August 19, 2013
| Version v1
Journal article
Open
Downregulation of ERp57 expression is associated with poor prognosis in early-stage cervical cancer
Description
Objective: We investigated the clinical significance of ERp57 in the progression of cervical
cancer.
Methods: mRNA and protein expression of ERp57 in cervical neoplasias were examined.
Results: ERp57 mRNA expression was significantly decreased in cervical cancers.
Immunohistochemistry revealed that ERp57 expression in 123 cervical cancers was downregulated
compared to cervical intraepithelial neoplasias or normal tissues (p50.001).
Low ERp57 expression was significantly associated with worse overall survival (HR¼12.19,
p¼0.018).
Conclusions: Low ERp57 expression independently predicts a poor outcome for patients with
cervical cancer, supporting the notion that ERp57 may be a promising novel cancer target.
Files
article.pdf
Files
(1.3 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:d680ac93f46c970eac67dddb10960800
|
1.3 MB | Preview Download |